Meridian Bioscience Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Meridian Bioscience last-minute Real Value cannot be determined due to lack of data. The latest price of Meridian Bioscience is $0.0. Our model forecasts the value of Meridian Bioscience from analyzing the firm fundamentals such as Profit Margin of 0.13 %, return on equity of 0.12, and Current Valuation of 1.39 B as well as examining its technical indicators and probability of bankruptcy.
Meridian Bioscience Total Value Analysis
Meridian Bioscience is at this time anticipated to have valuation of 1.39 B with market capitalization of 1.49 B, debt of 25 M, and cash on hands of 83.49 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Meridian Bioscience fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.39 B | 1.49 B | 25 M | 83.49 M |
Meridian Bioscience Investor Information
About 91.0% of the company outstanding shares are owned by institutional investors. The book value of Meridian Bioscience was at this time reported as 8.41. The company has Price/Earnings To Growth (PEG) ratio of 1.33. Meridian Bioscience last dividend was issued on the 1st of February 2019. The entity had 3:2 split on the 14th of May 2007. Based on the measurements of operating efficiency obtained from Meridian Bioscience's historical financial statements, Meridian Bioscience is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Meridian Bioscience Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Meridian Bioscience has an asset utilization ratio of 71.91 percent. This suggests that the Company is making $0.72 for each dollar of assets. An increasing asset utilization means that Meridian Bioscience is more efficient with each dollar of assets it utilizes for everyday operations.Meridian Bioscience Ownership Allocation
Meridian Bioscience maintains a total of 43.83 Million outstanding shares. The majority of Meridian Bioscience outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Meridian Bioscience to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Meridian Bioscience. Please pay attention to any change in the institutional holdings of Meridian Bioscience as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Meridian Bioscience Profitability Analysis
The company reported the previous year's revenue of 333.02 M. Net Income was 42.46 M with profit before overhead, payroll, taxes, and interest of 188.36 M.Meridian Bioscience Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 44 M | |
| Quarterly Earnings Growth Y O Y | -0.13 | |
| Forward Price Earnings | 40.6504 | |
| Retained Earnings | 223.2 M | |
| Retained Earnings Total Equity | 223.2 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in private. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in Meridian Stock
If you are still planning to invest in Meridian Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Meridian Bioscience's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |